What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to reaffirm Cigna's projected full-year 2019 consolidated adjusted income from operations, which is expected to remain in the range of $6.38 billion to $6.46 billion. This update is provided in the context of upcoming meetings with investors and analysts.

What is 'Adjusted income (loss) from operations' and why is it used?

Adjusted income (loss) from operations is a non-GAAP financial measure used by Cigna's management. It represents shareholders' net income excluding after-tax adjustments such as net realized investment results, amortization of acquired intangible assets, special items, and earnings from transitioning PBM clients. Management uses this metric to present and analyze the underlying operational results and trends of the company's businesses.

Can I reconcile the 'Adjusted income from operations' to GAAP net income for 2019?

Cigna's management states they are unable to provide a forward-looking reconciliation of adjusted income from operations to GAAP shareholders' net income. This is due to the unpredictable nature of certain future components, specifically net realized investment results and special items, which can vary materially and are often outside of the company's control.

What are the key risks mentioned in the filing that could affect Cigna's financial performance?

The filing highlights several risks, including the ability to achieve financial and operational plans, effectively manage medical and pharmacy costs, adapt to industry changes, differentiate products, maintain good provider relationships, manage the impact of drug pricing, integrate acquisitions (like the Express Scripts merger), navigate government regulation, and potential impacts from economic or political conditions. These factors could cause actual results to differ materially from forward-looking statements.

CI 8-K: Regulation FD — Nov 21, 2019

Summary

Cigna Group (CI) filed an 8-K on November 21, 2019, primarily to reaffirm its full-year 2019 financial outlook. Company officials indicated during investor and analyst meetings that they expect to reaffirm the projected consolidated adjusted income from operations to be in the range of $6.38 billion to $6.46 billion. This projection was previously discussed in their October 31, 2019, press release and subsequent investor call. The filing also includes cautionary statements regarding forward-looking information, emphasizing that actual results could differ materially due to various risks and uncertainties inherent in the company's business, including regulatory changes, competition, and the successful integration of past acquisitions, such as the Express Scripts merger. Investors should note that the provided adjusted income metric is a non-GAAP measure used by management for operational analysis and should not be viewed as a substitute for GAAP net income.

Key Highlights

1Cigna reaffirms its projected full-year 2019 consolidated adjusted income from operations to be between $6.38 billion and $6.46 billion.
2The company's officials are scheduled to participate in investor and analyst meetings over the coming weeks.
3The reaffirmed outlook was initially communicated in a press release dated October 31, 2019, and discussed on a related investor conference call.
4The filing includes a clear definition of 'Adjusted income (loss) from operations' as a non-GAAP profitability measure used by management.
5Management notes that reconciliation to the most directly comparable GAAP measure (shareholders' net income) cannot be provided on a forward-looking basis due to the unpredictability of certain components like net realized investment results and special items.
6The report contains standard forward-looking statements disclosing potential risks and uncertainties that could impact actual financial results.
7Key risks mentioned include achieving financial plans, managing medical and pharmacy costs, adapting to industry changes, integration of acquisitions (specifically mentioning the Express Scripts merger), and government regulation.

Cigna Group 8-K Report, Regulation FD Disclosure (Nov 21, 2019)

Summary

Key Highlights

Frequently Asked Questions